[HTML][HTML] Mesenchymal stem cells in the treatment of new coronavirus pandemic: a novel promising therapeutic approach

S Razi, Z Molavi, SA Mirmotalebisohi… - Advanced …, 2022 - ncbi.nlm.nih.gov
After severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome
(MERS) outbreaks, coronavirus disease 2019 (COVID-19) is the third coronavirus epidemic …

[HTML][HTML] Mesenchymal stem cell treatment for COVID-19

R Xu, Z Feng, FS Wang - EBioMedicine, 2022 - thelancet.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has caused a
global pandemic since late 2019 that resulted in more than 360 million population infection …

Mesenchymal Stem Cells Therapy for COVID-19: From Basic Research to Clinical Trial

YC Tao, EQ Chen - Current Stem Cell Research & Therapy, 2024 - ingentaconnect.com
The novel pathogenic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
causes coronavirus disease 2019 (COVID-19), a serious challenge for human health. In …

Clinical consideration for mesenchymal stem cells in treatment of COVID-19

KH Wu, YH Chao, TF Weng, JP Li - Current Pharmaceutical …, 2022 - ingentaconnect.com
COVID-19, which has strongly affected the 21st century, is caused by severe acute
respiratory syndrome (SARS)-CoV-2. The emergence of viral variants has rendered even …

Mesenchymal stem cell-based therapy for COVID-19: possibility and potential

J Xiong, L Bao, H Qi, Z Feng… - Current Stem Cell …, 2021 - ingentaconnect.com
A novel coronavirus, named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2) has emerged in Wuhan, China since the end of December 2019 and has quickly spread …

The use of mesenchymal stromal cells in the treatment of coronavirus disease 2019

MA Canham, JDM Campbell, JC Mountford - Journal of Translational …, 2020 - Springer
More than seven months into the coronavirus disease-19 (COVID-19) pandemic, infection
from the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has led to over …

Research progress of mesenchymal stem cell therapy for severe COVID-19

Q Cai, F Yin, L Hao, W Jiang - Stem Cells and Development, 2021 - liebertpub.com
Corona virus disease 2019 (COVID-19) refers to a type of pneumonia caused by severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Sixty million confirmed …

Mesenchymal stromal cells and pleiotropic therapeutic advantages in COVID-19 management

VK Singh, UKS Vaksh, P Sharma - Stem Cells, 2024 - Elsevier
The pandemic burst of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or
coronavirus disease 2019 (COVID-19) infections shattered existing medical and research …

Clinical Trials of Mesenchymal Stem Cells for the Treatment of COVID 19

E Zendedel, L Tayebi, M Nikbakht… - Current Stem Cell …, 2024 - ingentaconnect.com
Mesenchymal Stem Cells (MSCs) are being investigated as a treatment for a novel viral
disease owing to their immunomodulatory, anti-inflammatory, tissue repair and regeneration …

Stem cells as therapeutics and their implications in cytokine storm in COVID-19

P Surya, S Tomar, R Pandey, S Pathak, P Sharma… - Stem Cells, 2024 - Elsevier
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that causes the
coronavirus illness 2019 (COVID-19) has burdened health officials around the world. Acute …